Vyvanse Cost in Maine 2026: Prices, Insurance, Savings Programs

Vyvanse (lisdexamfetamine dimesylate) is a Schedule II stimulant medication that converts to dextroamphetamine in the body. The FDA approved it to treat ADHD in children 6 and up, as well as moderate-to-severe binge eating disorder in adults. Generic versions of lisdexamfetamine became available in the U.S. market after FDA approval in August 2023.

The direct answer: what you pay for lisdexamfetamine in Maine depends far more on whether you use generic or brand, and on your specific insurance formulary tier or MaineCare prior authorization status, than on where in Maine you live. Manufacturer list price for brand Vyvanse is set nationally, not by state, and MaineCare's pharmacy benefit rules apply statewide rather than by county. Any specific dollar figure quoted for "average Maine price" changes month to month and pharmacy to pharmacy, so treat single-number price claims as a starting estimate to verify, not a guarantee.

What is established, what is plausible, and what is not established

Established: Lisdexamfetamine has FDA-approved indications for ADHD and binge eating disorder, generic versions exist from multiple manufacturers, MaineCare covers the drug class through its pharmacy benefit with prior authorization for many stimulants, and manufacturer copay savings cards and patient assistance programs exist for Takeda's brand product.

Plausible but not independently confirmed here: Specific cash-pay averages (such as a single dollar figure for "the Maine price"), specific insurer-by-insurer copay ranges, and specific compounding pharmacy price points. These numbers move frequently and were not verifiable from primary sources for this draft.

Not established from the sources available: Any claim of a fixed statewide "average" cash price for a given month, or a guaranteed savings card dollar cap, since manufacturer coupon terms and pharmacy cash pricing change without a fixed public update schedule.

Brand versus generic: the real cost lever

The FDA's generic drug approval standard requires a generic product to be bioequivalent to the brand, meaning it delivers the same active drug at a comparable rate and extent into the bloodstream. This standard, not manufacturer identity, is why clinicians and pharmacists generally treat FDA-approved generic lisdexamfetamine as interchangeable with brand Vyvanse for most patients. Brand Vyvanse carries a substantially higher list price than generic lisdexamfetamine at nearly every pharmacy nationwide, and Maine pharmacies are very unlikely to be an exception to that general pattern. Exact current dollar amounts for brand list price, generic cash price, and coupon price should be checked at the point of fill, because they change and because pharmacy-to-pharmacy variation within Maine can be as large as month-to-month variation at a single pharmacy.

MaineCare (Maine Medicaid) coverage

MaineCare's pharmacy benefit operates through a preferred drug list with prior authorization requirements for many stimulant medications, consistent with how most state Medicaid programs manage controlled-substance ADHD medications. A prior authorization typically requires the prescriber to document a qualifying diagnosis and, in many state Medicaid programs, evidence that a first-line agent was tried or a clinical reason it was not appropriate. Exact MaineCare criteria, current preferred/non-preferred status for lisdexamfetamine, prior authorization turnaround times, and current copay amounts are set by the Maine Department of Health and Human Services and can change between plan years. These specifics should be confirmed directly with MaineCare or your MaineCare-enrolled pharmacy rather than assumed from this article, since no verified MaineCare-specific pricing document was available to support precise figures here.

Compounded lisdexamfetamine: what is actually different

Compounding is a legitimate, regulated practice. A 503A pharmacy compounds a medication for an individual patient based on a specific prescription, which differs from a 503B outsourcing facility that produces batches without patient-specific orders. Compounding is generally appropriate when a commercially available strength or form does not meet a documented clinical need, such as a dose strength that does not exist commercially or a patient who cannot swallow capsules. It is not a routine cost-saving substitute for a commercially available product, and most commercial insurance plans and MaineCare typically do not cover compounded stimulant preparations, so out-of-pocket cost varies by pharmacy and should be quoted directly before filling. Confirm that any Maine pharmacy offering compounded lisdexamfetamine holds an active 503A license through the Maine Board of Pharmacy.

Insurance coverage in Maine: what generally applies, and what needs plan-level verification

Most health plans position generic lisdexamfetamine in a more favorable formulary tier than brand Vyvanse and frequently require prior authorization or step therapy before approving brand Vyvanse. The ACA mandates marketplace plan coverage of mental health and substance use services, which establishes the foundation for ADHD treatment coverage. However, copay amounts, formulary placement, and authorization requirements vary significantly between insurers, plans, and calendar years, and reset during open enrollment periods. Without a current, verified formulary from your specific Maine insurer, quoted copay amounts can quickly become outdated; verify your actual copay by calling the number on your insurance card or reviewing your plan's latest formulary.

Manufacturer savings card and patient assistance

Takeda, Vyvanse's manufacturer, maintains a copay assistance card for eligible patients with commercial insurance and a separate program for uninsured patients meeting income thresholds. These programs typically do not extend to patients covered by Medicaid, Medicare, Tricare, or VA insurance, and Takeda periodically adjusts program rules, maximum benefits, and eligibility requirements. Check Takeda's current patient support website or call the number on the assistance card to verify the present benefit level. Since generic lisdexamfetamine is now readily accessible, many patients find the generic price (whether paid out-of-pocket or through insurance) lower than the final copay for brand Vyvanse after applying a manufacturer's savings card; it's worth comparing both options at your pharmacy before choosing the savings card approach.

Telehealth prescribing in Maine

Federal rules governing telehealth prescribing of Schedule II controlled substances, including lisdexamfetamine, have been the subject of repeated temporary extensions and proposed permanent rules from the DEA. Whether an initial lisdexamfetamine prescription can be issued after a video-only evaluation, and how long a patient can continue on telehealth-issued Schedule II prescriptions before an in-person visit is required, depends on the current DEA rule in effect at the time of prescribing. This is a date-sensitive regulatory fact. Verify the current rule at the DEA's own regulatory pages or at fda.gov/regulatory-information before relying on any specific "90-day" or similar figure, since these thresholds have changed and could change again.

Clinical facts that affect cost decisions but not the price itself

Lisdexamfetamine capsules are available in 10, 20, 30, 40, 50, 60, and 70 mg strengths. Per FDA labeling, the drug is pharmacologically inactive until enzymatic cleavage in the body releases active dextroamphetamine, which produces its gradual-onset stimulant effect. Dose strength generally does not change the cash price of a 30-day supply at most pharmacies, which is a genuine, underused decision point: patients working with a prescriber on dose titration are not typically penalized financially for using an intermediate strength versus the maximum approved dose. Individual dosing decisions should be made with a prescriber and are not something this article can specify for a given patient.

Vyvanse cost verification checklist: stable facts versus facts you must recheck

Use this before you assume any number in this article, a coupon site, or a forum post still applies.

Stable facts (federal or clinical, unlikely to change month to month):

• Lisdexamfetamine is FDA-approved for ADHD (age 6+) and moderate-to-severe binge eating disorder in adults.
• Generic lisdexamfetamine has been FDA-approved and commercially available since August 2023.
• FDA bioequivalence standards apply to all approved generics regardless of manufacturer.
• 503A compounding requires a patient-specific prescription and a licensed compounding pharmacy; 503B facilities do not compound patient-specific orders.
• Capsule strengths (10 through 70 mg) and the prodrug mechanism described on the FDA label.

Volatile facts you must reverify before relying on them (recheck at the date you read this):

• MaineCare's current preferred drug list status, prior authorization criteria, and turnaround time for lisdexamfetamine, confirm with MaineCare or the Maine DHHS pharmacy benefit page.
• Cash-pay price at any specific Maine pharmacy or on any discount coupon platform.
• Any specific commercial insurer's copay tier, prior authorization rule, or step therapy requirement for lisdexamfetamine in Maine.
• Takeda's savings card maximum benefit, eligibility rules, and patient assistance program income threshold.
• The current DEA telehealth prescribing rule for Schedule II controlled substances, including any in-person visit requirement and its timing.
• Any given compounding pharmacy's price quote for a custom dose or formulation.

If a number in an article, ad, or coupon site does not match what your pharmacy, insurer, or MaineCare tells you directly, trust the direct source over the article.

How to approach paying less

• If you have MaineCare, ask your prescriber to request generic lisdexamfetamine and confirm current copay and prior authorization status directly with MaineCare.
• If you have commercial insurance, ask your pharmacist to run both your insurance claim and a current discount coupon for generic lisdexamfetamine, and compare the two totals at the counter, especially early in the plan year before a deductible is met.
• If you are uninsured, a current discount coupon for generic lisdexamfetamine at a Maine retail pharmacy is generally the lowest-cost cash option, but get a specific quote rather than relying on a remembered or advertised price.
• If you specifically need brand Vyvanse, check your plan's current coverage for the brand and Takeda's current savings card terms before assuming it beats the generic cash price.
• If you need a dose strength or form that is not commercially available, ask your prescriber about a licensed 503A compounding pharmacy and get a direct price quote before filling.

When to involve your prescriber or seek urgent care

Cost pressure should never lead to skipping doses, splitting capsules without guidance, or switching between brand and generic without telling your prescriber, since dose equivalence assumptions can be wrong for an individual patient. Contact your prescriber if cost is preventing you from filling a prescription as written, if you experience new cardiovascular symptoms (chest pain, palpitations, fainting), significant mood changes, or signs of misuse or dependence. Seek urgent or emergency care for chest pain, severe agitation, hallucinations, or suspected overdose.